Operating
Stock-Based Comp
Boston Scientific Stock-Based Comp increased by 16.9% to $83.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 12.2%, from $74.00M to $83.00M. Over 4 years (FY 2021 to FY 2025), Stock-Based Comp shows an upward trend with a 11.4% CAGR.
Analysis
StatementCash Flow Statement
SectionOperating
CategoryCapital Allocation
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase may signal a strategy to preserve cash or align employee interests with shareholders, but it also results in share dilution.
Detailed definition
Stock-based compensation is a non-cash expense where employees and executives are rewarded with equity or stock options...
Peer comparison
High-growth technology firms often have higher stock-based compensation as a percentage of revenue compared to mature industrial firms.
Metric ID:
stock_based_compensationHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $47.00M | $51.00M | $49.00M | $52.00M | $55.00M | $58.00M | $55.00M | $55.00M | $60.00M | $59.00M | $59.00M | $63.00M | $66.00M | $68.00M | $69.00M | $74.00M | $75.00M | $79.00M | $71.00M | $83.00M |
| QoQ Change | — | +8.5% | -3.9% | +6.1% | +5.8% | +5.5% | -5.2% | +0.0% | +9.1% | -1.7% | +0.0% | +6.8% | +4.8% | +3.0% | +1.5% | +7.2% | +1.4% | +5.3% | -10.1% | +16.9% |
| YoY Change | — | — | — | — | +17.0% | +13.7% | +12.2% | +5.8% | +9.1% | +1.7% | +7.3% | +14.5% | +10.0% | +15.3% | +16.9% | +17.5% | +13.6% | +16.2% | +2.9% | +12.2% |
Range$47.00M – $83.00M
CAGR+12.7%
Avg YoY Growth+11.6%
Median YoY Growth+12.9%
Stock-Based Comp at Other Companies
Frequently Asked Questions
- What is Boston Scientific's stock-based comp?
- Boston Scientific (BSX) reported stock-based comp of $83.00M in Q1 2026.
- How has Boston Scientific's stock-based comp changed year-over-year?
- Boston Scientific's stock-based comp increased by 12.2% year-over-year, from $74.00M to $83.00M.
- What is the long-term trend for Boston Scientific's stock-based comp?
- Over 4 years (2021 to 2025), Boston Scientific's stock-based comp has grown at a 11.4% compound annual growth rate (CAGR), from $194.00M to $299.00M.
- What does stock-based comp mean?
- The value of company shares given to employees as part of their pay.